ClinicalTrials.gov
ClinicalTrials.gov Menu

Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00002677
Recruitment Status : Completed
First Posted : May 11, 2004
Last Update Posted : March 30, 2017
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Maryland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2003
  Actual Study Completion Date : March 2003